PTPRC and plasma cell myeloma: Along with elevated serum immunoglobulin and osteolytic bone disease, multiple myeloma (MM) is characterized by the clonal expansion and accumulation of mature and quiescent CD45-CD138+ antibody secreting neoplasic plasma cells in the bone marrow.